the ICU and had significant functional limitations 1 year later because of muscle wasting and fatigue. The median 6-minute walk distance in survivors was only 66% of that predicted at 1 year after ICU discharge, with limitations attributed to ICU-acquired morbidities, such as global muscle wasting and weakness, foot drop, joint immobility, and dyspnea. Only 49% of survivors in this study had returned to work at 1 year after discharge. In a systematic review of ICU patients with sepsis, multiorgan failure, or prolonged mechanical ventilation, neuromuscular dysfunction was identified in 46% of patients and was associated with prolonged duration of mechanical ventilation and length of ICU and hospital stay. 31 After 7 days of mechanical ventilation, 25-33% of patients experience clinically visible weakness. 11 In a recent study, clinicians found that more than one third of patients with stays in the ICU greater than 2 weeks had at least 2 functionally significant joint contractures.
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Low patient mobility is rampant in current ICU practice. A multicenter study of patients with acute lung injury found that only 27% of patients received physical therapy in the ICU, with therapy occurring on only 6% of all ICU days; 26 another single-center study found that only 6% of mechanically ventilated patients received physical therapy in the ICU. 25 Krishnagopalan et al. 21 demonstrated that during an 8-hour time frame, fewer than 3% of critically ill patients were turned, even though ICU policy mandated turning patients every 2 hours, and that approximately 50% of patients had no change in body position at all. Finally, Goldhill et al.
14 found that the average time between manual turns was 4.85 ± 3.3 hours among 40 different ICUs.
With more than 5 million persons experiencing an ICU stay each year, the short-and long-term complications of immobility and bed rest significantly affect patient morbidity, mortality, cost, and quality of life. 17 No study has investigated the feasibility or benefit of increased mobility on outcome in the neurointensive care unit population. Furthermore, the neurointensive care unit, given its high rate of immobility due to neurological dysfunction, may be an ideal setting for such an intervention. In this paper we present the results of a prospective trial of a comprehensive mobility program among neurointensive care unit patients at a single center.
Methods
Shands Hospital at the University of Florida is an 852-bed, tertiary-care medical center with 142 intensive care beds, 30 of which constitute the neurointensive care unit. The neurointensive care unit is overseen by an interdisciplinary team composed of vested members from neurosurgery, neurology, critical care medicine, nursing, and social work. Its membership includes neuroscience critical care staff nurses, nurse leaders, social workers, pharmacists, physician extenders, and physicians.
Patients and Study Design
The study population consisted of all consecutive patients admitted to the neurointensive care unit from April 1, 2010, through July 31, 2011 (n = 3291). Patients were excluded for age < 18 years, hemodynamic instability, or end of life care. The study consisted of a 10-month preintervention surveillance period (April 1, 2010, through January 31, 2011) followed by a 6-month prospective intervention phase (February 1-July 31, 2011). Study approval was granted by the Institutional Review Board at the University of Florida and Shands Hospital.
Mobility Intervention
The Comprehensive Mobility Guidelines were developed by the SUF Mobility Task Force, a hospital-wide interdisciplinary team that includes representatives from hospital administration, departmental physicians, rehabilitation, physical therapy, clinical nurse leaders, and quality management. A literature review was performed and evidence-based best practices were reviewed in detail. Mobility protocols were developed for critical care units and general hospital floors based on evidence review. In addition, a mobility bundle toolkit was developed that included recommendations for equipment purchasing, staff education plans, validation checklists, and practical implementation advice for medical and nursing leaders. The Neuroscience Center inpatient units (neurointensive care unit and two medical/surgical floors) were the pilot units for testing the new mobility protocol. The mobility bundle toolkit was then distributed to each unit's nursing leadership team for duplication.
The keystone of the critical care component of the Comprehensive Mobility Guideline is the PUMP Plus algorithm. Progressive mobility is a series of planned movements in a sequential manner beginning at a patient's current mobility status with a goal of returning to his or her baseline level. 33 The PUMP Plus algorithm was developed and modified using existing evidence and guidelines including "Progressive Mobility Guidelines for Critically Ill Patients"
1 and "Progressive Upright Mobility (PUM) in the ICU: The How-to-Guide" 22 at the University of Kansas. The "plus" part of this protocol was the addition of 6 levels for rehabilitation of patients beyond previous protocols (Fig. 1 ). Steps 6-11 provide clear expectations for patients beyond being "out-of-bed to chair," which was previously the ultimate mobility "goal" in ICU patients.
A neurocritical care subgroup of the SUF Mobility Task Force added these 6 advanced levels to prevent major deconditioning among able patients without requiring the consultation of the physical therapy team. The stages of PUMP Plus consist of elevating the head of the bed, tilting the bed, sitting in an upright position, sitting on the edge of the bed, standing, sitting in a chair, ambulating in the room, ambulating outside of the room, and exercises as determined by physical therapy/occupational therapy. As patients completed each stage they were automatically encouraged to progress to the next step rather than await a physician's orders; however, a patient's maximum activity level could still be determined by physicians. It was believed that this component was critical for the neurointensive care unit population because there are significant numbers of patients who are maintained in the neurointensive care unit for detailed monitoring and/or blood pressure and fluid management despite good neurological function (such as patients with subarachnoid hemorrhage).
Importantly, a neurointensive care unit policy, initiated by the medical directors and agreed upon by all attending physicians in the unit, stated that enrollment in the PUMP Plus program was automatic unless clinically contraindicated and documented by the attending physician. This was an important factor because it communicated to the nursing staff that PUMP Plus and mobility were the standard of care and to not mobilize the patient was the exception. This is an important factor in changing the culture of ICU patients who traditionally have been placed on bed rest because of the perception that they are too sick to be out of bed. A physician's order was required to discontinue PUMP Plus in neurointensive care unit patients. Clinical contraindications for PUMP Plus included unstable spine, active stroke alerts, and/or up to 24 hours after tissue plasminogen activator and endovascular intervention, increased intracranial pressure, active resuscitation for life-threatening hemodynamic instability, femoral sheaths, traction, continuous renal replacement therapy, or aggressive modes of ventilation and palliative care. However, ventriculostomies (in the off position) are not a contraindication to PUMP Plus.
Additional aspects of the Comprehensive Mobility Guidelines included criteria for use of skilled physical therapy and occupational therapy services, purchasing additional assistive equipment, funding for additional mobility aides, blocked time scheduling for rehabilitation services, and requiring all patients without specific clinical contraindications to be out of bed for meals, showering, and toilet use.
Data Collection
Demographic information, including morbidity, neurointensive care unit LOS, and diagnosis, was obtained from Decision Support Services and chart review. The neurointensive care unit LOS was calculated as a monthly average for the neurointensive care unit. Hospital LOS was determined for each patient in the 2-week pre-and postintervention observation period by chart review.
Mobility was assessed by the I-MOVE tool. 23 The I-MOVE tool (Appendix A) records the highest level of mobility obtained by a patient within the previous hour. The stages included sitting upright in bed (1 point), sitting on the edge of the bed (10 points), getting out of bed (20 points), walking to the bathroom (30 points), walking outside the room (40 points), or exercising (50 points). All information was recorded by bedside nurses hourly and analyzed during a 2-week collection period immediately preceding the initiative (January 18-31, 2011) and for another 2-week period (May 31-June 14, 2011) 4 months after initiation of the mobility initiative.
Pressure ulcer data were collected by an Ostomy and Wound Liaison nurse during weekly "Skin Rounds" ev- ery Wednesday using the National Pressure Ulcer Advisory Panel rating scale.
7 All patients were assessed for the presence of pressure ulcers. The pressure ulcers were categorized according to the National Pressure Ulcer Advisory Panel scale and ranged from "Stage I" to "Deep Tissue Injury." The results presented are Stage II and higher "unit acquired" pressure ulcer prevalence.
Patient falls and inadvertent tracheal extubations, as well as unplanned central venous catheter and external ventricular drain removals, were used as indicators of protocol safety. These events were recorded as incident reports within a preexisting adverse event monitoring system.
Hospital-acquired infection data were regularly collected as part of the quality improvement measures and were reported to the Agency for Healthcare and Research Quality. Hospital-acquired infections were defined by the NHSN criteria.
Ventilator-Associated Pneumonia. Ventilator-associated pneumonia requires that the patient has an artificial airway (endotracheal tube or tracheostomy) and is mechanically ventilated for more than 48 hours at the time of culture, or within the 48 hours prior to the onset of the event. Ventilator-associated pneumonia criteria can be met by radiographic, clinical, and/or laboratory criteria as follows.
Radiographic criteria require 2 or more serial chest radiographs with at least 1 of the following: new or progressive and persistent infiltrate, consolidation, cavitation, or pneumatoceles. Clinical criteria require at least 1 of the following: fever (> 38°C), leukopenia (< 4000 white blood cells/mm 3 ) or leukocytosis (> 12,000 white blood cells/mm 3 ), or for adults more than 70 years old, altered mental status. In addition, at least 1 of the following is present: new onset of purulent sputum, increased respiratory secretions, increased suctioning requirements, new onset or worsening cough, dyspnea, tachypnea, rales, bronchial breath sounds, and worsening gas exchange (O 2 desaturations [PaO 2 /FiO 2 < 240], increased O 2 requirements, or increased ventilator demand). Laboratory criteria require at least 1 of the following: positive growth in blood culture not related to another source of infection, positive growth in pleural fluid culture, positive quantitative culture from minimally contaminated lower respiratory tract specimen (bronchoalveolar lavage or protected specimen brushing), and ≥ 5% bronchoalveolar lavageobtained cells containing intracellular bacteria on direct microscopic examination (Gram stain) or by histopathological examination. Ventilator-associated pneumonia was excluded if the patient was within 48 hours of transfer from another facility. The VAP rate per 1000 ventilator days was calculated by dividing the number of VAPs by the number of ventilator days and multiplying the result by 1000. The Infection Control Practitioner gathered data on the patient (signs/symptoms, chest radiographs, treatment, and other data) and referred any positive finds to physicians in the Infectious Disease department who reviewed the case and determined whether a VAP met the NHSN definitions.
Catheter-Associated UTI. A catheter-associated UTI was an infection that occurred while the patient had a urinary catheter in place, or had a catheter in place within 48 hours prior to culture. 19 Two possible definitions of UTI were accepted. The first definition included a patient who had at least 1 sign or symptom of UTI and a positive urine culture growing > 10 5 cfu/ml with no more than 2 microorganisms. Signs and symptoms include temperature > 38°C, urinary urgency, urinary frequency, dysuria, and suprapubic tenderness. The second definition required that a patient have at least 2 signs or symptoms but a less compelling laboratory finding such as a positive dipstick for leukocyte esterase or nitrite, pyuria with ≥ 3 white blood cells/hpf, positive Gram stain, or 2 urine cultures > 10 2 cfu/ml of a single pathogen in a patient undergoing treatment with antimicrobial agents. Asymptomatic catheter-associated bacteriuria or candiduria was defined as a positive urine culture (> 10 5 cfu/ml) in a patient who had had a urinary catheter within the previous 2 days and who had no signs or symptoms of catheter-associated UTI. Asymptomatic catheter-associated bacteriuria or candiduria were not counted as catheter-associated UTIs in this study. Patients were not routinely monitored for asymptomatic bacteriuria. Urinalysis as well as urine and blood cultures was performed whenever the patients developed systemic or local signs of infection; these included fever (temperature > 38.5°C), urinary urgency, urinary frequency, dysuria, and suprapubic tenderness.
The infection control investigation of possible catheter-associated UTI was triggered by a positive urine culture. An infection control nurse practitioner would then perform a chart review to gather data. These data were presented to the hospital epidemiologist to decide whether an infection based on NHSN definitions had occurred. Catheter-associated UTI rate was defined as the number of patients with catheter-associated UTI divided by the number of indwelling urinary catheter days multiplied by 1000. Catheter utilization was defined by the NHSN definition, which was the total number of catheter days divided by the total number of patient days multiplied by 100.
Education
The SUF Mobility Task Force developed and executed a comprehensive education and implementation plan. This plan included policy and guideline development; equipment inventory and purchasing; interdisciplinary education; skills validation checklists for physicians, nurses, and therapists; data collection tools; and shiftto-shift monitoring via a newly designed support technician role. Interdisciplinary educational modules were written and videos were developed to assist learners with practical implementation of the Comprehensive Mobility Guidelines. This education was electronically distributed to all frontline care providers as a mandatory requirement. In addition, the hospital-wide preoperative surgery and unit admission patient education brochures were revised to include the Comprehensive Mobility Guidelines. This education plan was so successful in changing the culture on the neurointensive care unit that the SUF Mobility Task Force "bundled" it into a toolkit for unit managers throughout the hospital. Elements of the Mobility Checklist are listed in Table 1 .
Slogan promotion was also used to increase awareness on the unit. Best practices were built into order sets as defaults. Each department was provided a monthly update of their current infections and targets, as well as the percentage compliance of each physician with the PUMP Plus.
Statistical Analysis
A mixed linear model was used to estimate the effects of the variables of interest on mobility score (SAS PROC MIXED, version 9.1). Independent variables were sex, diagnosis group, treatment, day of stay (considered as an ordered, continuous variable), age, and the diagnosis-group × day interaction. We used an unstructured covariance matrix. We used log(mobility + 1) to meet linear model assumptions (the data were highly nonnormally distributed). We added 1 to each mobility score before taking the log because some mobility observations were 0.
Pre-and postintervention LOS and mortality information were compared using 2-sample t-tests, and diagnosis group was compared using the chi-square test. A probability value < 0.05 was considered statistically significant. Sample size predictions were made with an a error of 5% and a b error of 50% and were determined prior to study initiation.
Results

Comprehensive Mobility Initiative and Patient Mobility
The PUMP Plus program compliance was assessed during a 1-month period prior to the second mobility data collection period. The neurointensive care unit Clinical Leader reviewed each neurointensive care unit patient daily to determine whether PUMP Plus was being performed and found that 93.8% ± 4% of patients who had no contraindication to the protocol were participating. On average only 10.6% ± 4.7% of patients had to discontinue the PUMP plus program for clinical contraindications. Additionally, 2.2% ± 0.2% of patients per day refused to participate and only 1.4% ± 0.2% of patients had the protocol discontinued for inappropriate or indiscernible reasons.
Mobility data were collected during two separate 2-week periods on a total of 166 patients. The first data were collected immediately prior to implementation of the mobility initiative and the second data collection occurred 4 months into the initiative. The late date of the second collection period allowed for complete adoption of all mobility initiatives. There was no difference in the age (p = 0.46), sex (p = 0.81), or diagnosis of the patient population (p = 0.33) before and after intervention ( Table  2 ). The estimated true means of the global mobility score, as assessed by the I-MOVE tool, increased by 300% from 14.5 before the intervention to 44.7 following the intervention after controlling for age, diagnosis, neurointensive care unit LOS, and sex (p < 0.0001; Table 2 ). More importantly, the number of patient days on which a score of zero was recorded on the I-MOVE tool decreased from 92 patients (47.3%) to 27 patients (8.3%) after the intervention. Further analysis of the mobility steps as recorded by the I-MOVE tool show that after initiation of the PUMP Plus program the average patient more frequently sat up in bed (p < 0.05), got out of bed (p < 0.001), and walked to the bathroom (p < 0.001), but no patient exercised before or after the intervention (Fig. 2) . Our mixed linear model indicated that treatment, diagnosis group, and the day of neurointensive care unit stay were highly significant predictors of mobility score (c 2 = 174.6, degrees of freedom = 1, p < 0.0001). Not surprisingly, sex was not a significant predictor of mobility (p = 0.36), and unexpectedly neither was age (p = 0.26). Mobility generally increased as a patient's time in the neurointensive care unit passed.
Finally, when comparing the sample groups, hospital LOS decreased significantly from 12 days before the mobility protocol to 8.6 days after implementation after controlling for diagnosis group (p < 0.01; Table 2 ). Not surprisingly, mobility score was a significant predictor of hospital LOS (p < 0.004), with LOS tending to decrease with increasing mobility score. It is estimated that LOS decreases by 0.2% for each unit increase in mobility score (95% CI 0.9969-0.9994).
Increased Mobility, Decreased Neurointensive Care Unit LOS, and Hospital-Acquired Infections
Outcome measures were tracked throughout the 10-month preintervention (8025 patient days) and 6-month postintervention periods (4455 patient days) and compared. The monthly average neurointensive care unit LOS significantly decreased by 13% from 4.0 days prior to the intervention to 3.46 after the intervention (p < 0.004). No significant difference was observed in the secondary out- unit care form unit-specific goals review your current equipment inventory, purchase new equipment as needed determine and measure unit endpoint outcomes (such as mobility compliance, LOS), measure before and after roll-out data collection educate nursing staff on mobility guidelines/protocol/equipment educate physician staff to mobility guidelines/protocol educate other disciplinary staff (RT/PT/OT) to mobility initiative update whiteboards in patient rooms with mobility education/goals template set up patient/family education board in unit-specific waiting room determine a go-live date, communicate it and implement recommend daily unit-level surveillance to enforce compliance approximately 2-4 weeks after go-live, consider support technician role or something similar incorporate endpoint measurements into unit-level dashboards and quality plan * OT = occupational therapist; PT = physical therapist; RT = respiratory therapist.
comes of unit-acquired pressure ulcers (p = 0.22). However, a significant 18.3% drop in the number of patient days in restraints was observed (p < 0.05).
Increased mobility appeared to have the most pronounced inverse correlation with hospital-acquired infections (Table 3 ). The average number of hospital-acquired infections decreased by 60% when comparing the preand postintervention periods (from 5.5 ± 0.9 to 2.2 ± 1.0, respectively; p < 0.05; Fig. 3 ). Hospital-acquired infections in this study consisted of VAPs, central venous line infections, and catheter-associated UTIs. Of these infections, the greatest effect was noted on the VAP rate. Before the intervention there were 2.14 ± 0.95 VAP cases per 1000 ventilator days and after the intervention none were observed during the 6-month follow-up period (p < 0.001). This is underscored by the fact that no significant differences in number of ventilator days (p = 0.39), percentage of patients ventilated (p = 0.66), or compliance with the VAP bundle (p = 0.23) were observed during the same time period. While statistically insignificant, there was a clinically significant reduction in the unit catheterassociated UTI rate of 61% (2.72 ± 1.17 before vs. 1.07 ± 1.67 after; p = 0.11). This was likely related to the reduction in average number of catheter days per month, which was decreased by 20.4%. Not surprisingly, urinary catheter duration was the factor most strongly correlated with the likelihood of catheter-associated UTI. 9 There was no significant change in central venous line infections between the pre-and postintervention period (p = 0.24). It is important to note that review of the LOS, VAP, or days in restraints from the opening of the neurointensive care unit in 2008 revealed no major declines prior to the onset of the PUMP Plus program, indicating that this change was not a coincidence but more likely a significant interaction.
Increased Mobility and Adverse Events
Every intervention has associated risks and benefits. To assess the risks associated with increased mobility in the neurointensive care unit, patient falls, critical line pulls, and total line pulls were monitored (Table 3) . Both the total number of falls per month (mean 1.00 vs 1.00, respectively) and the fall rate per 1000 patient days (1.39 vs 1.31, respectively) were essentially identical before and after the intervention. Similarly there was no significant difference in the total line pull rate (p = 0.766) or the rate of critical line pulls (p = 0.63). A critical line pull was defined as the total number of self-extubations, pulled arterial lines, and inadvertent external ventricular drain removals. The lack of increase in adverse events demonstrates the safety of this protocol in the neurointensive care unit patient population.
Discussion
This study provides evidence that a hospital-wide Comprehensive Mobility Campaign can result in increased mobility in neurointensive care unit patients. It must be noted that the mobility assessment used in this study, the iMOVE tool, while previously reported as a validated instrument, is composed of the same elements as the PUMP Plus itself. Therefore, it is not surprising that this tool was a sensitive measure of the PUMP Plus program. We additionally found that these increases in mobility occurred without increased falls or critical line pulls, and that increased mobility correlated with an observed decrease in neurointensive care unit LOS, hospital LOS, hospital-acquired infections in the neurointensive care unit, and decreased days in restraints. A 13% decrease in neurointensive care unit LOS was observed without a significant difference in mortality rate. A 28% decrease was observed in the total hospital LOS, from 12 days before the intervention to 8.6 days after the intervention, when adjusted for diagnosis, age, and sex. This result is in agreement with those from previous mobility studies. One study, 25 in a medical ICU that utilized a similar Mobility Team and protocol model, showed that ICU LOS decreased by 20% and hospital LOS decreased by 23% when adjusted for body mass index and vasopressor use. The similarity in these results is encouraging and suggests the reproducibility among differing types of ICU environments.
Early mobility of patients is not a new concept. The early ambulation of hospitalized patients was first introduced late in World War II in an effort to expedite the recovery of soldiers for return to the battlefield. 6 In 1972, the University of Colorado published a photo-illustrated report describing ambulation of a mechanically ventilated patient recovering from respiratory failure. 29 Another publication in 1975
8 from Geisinger Medical Center, in Danville, Pennsylvania, provides similar historical evidence of early ambulation for ICU patients.
Even minor increases in activity have shown beneficial effects in ventilated ICU patients. Twenty prospective randomized controlled trials on rotational therapy in ventilated patients were published between 1987 and 2004, and showed decreases in the incidence of pneumonia. 15 However, studies supporting the early onset of rehabilitation and, more importantly, ambulation in the acute ICU setting are relatively new. The first published report was an uncontrolled study of routine multidisciplinary, twice-daily rehabilitation therapy in the ICU provided to 103 mechanically ventilated patients. This study demonstrated that activity, including sitting and ambulation, was feasible and safe in mechanically ventilated patients. 4 Moreover, this study demonstrated benefit, with 69% of these ICU patients ambulating more than 100 feet (30 m) by ICU discharge with a mean distance walked of 212 feet (65 m). Thus far, only 1 study 25 has used a Mobility Team and Mobility Protocol to initiate earlier physical therapy in ICU patients. Morris et al. found that protocol patients were out of bed 6 days earlier (5 vs 11) and had therapy initiated more frequently (91% vs 13%, respectively) and that ICU LOS was 5.5 vs. 6.9 days (p = 0.025). Finally, hospital LOS decreased from 14.5 to 11.2 days (p = 0.006) when adjusted for body mass index and vasopressor usage.
The correlation between increased mobility and decreasing VAP rate was the least surprising finding in this study. Even minor increases in activity have shown beneficial effects in ventilated ICU patients. Rotational therapy alone, without ambulation, decreases the incidence of pneumonia but has no effect on duration of mechanical ventilation, number of days in intensive care, or hospital mortality. 15 Accordingly, the European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients recently endorsed evidence-based targets for physiotherapy in the ICU. These targets included deconditioning, impaired airway clearance, atelectasis, intubation avoidance, and weaning failure. 16 It is believed that the mucocilliary escalator performs suboptimally when prone and therefore increased upright mobility may allow for increased clearance of secretions.
Changes in the catheter-associated UTI rate after increased mobility is currently unreported. It is well established that the duration of catheterization is directly related to the risk of developing a UTI, with a risk of 3%-10% per day of catheterization. At 1 month, this risk is nearly 100%.
9 A retrospective cohort study of 400,000 nursing home patients showed that the ability to walk was associated with a 69% lower rate of hospitalization for UTI and that maintaining or improving mobility reduced the risk of hospitalization for UTI by 38% to 80%. 28 One possible explanation is that increased mobility either required the discontinuation of catheters or at least prompted physicians to discontinue the use of these catheters more frequently. In 1 study by Saint et al., 30 almost 40% of attending physicians of patients with unnecessary urinary catheters were unaware that the patient had a urinary catheter in place. This idea is reinforced by the significantly reduced number of catheter days after initiation of the mobility protocol in this study.
It bears mentioning that prior to this mobility project a VAP and UTI initiative had been enacted in our neurointensive care unit. However, these interventions predated this initiative by more than 6 months. More importantly, the VAP rate had stabilized prior to beginning the PUMP Plus program. Finally, there were no changes in either the VAP or UTI protocols during this trial in an attempt to control confounding variables.
It was our hypothesis that increased mobility would correlate with a decreased incidence of pressure ulcer prevalence, but this was not supported by the data. Decreased mobility has been shown by multiple authors to be an independent risk factor for the creation of pressure ulcers. Keller et al., 20 in a systematic review of the literature, found that decreased mobility was 1 of the 11 likely risk factors for pressure ulcer formation. Allman et al., 3 in a prospective inception cohort study of 286 patients, found that immobility had a relative risk increase of 2.36 for pressure ulcer development. Batson et al., 5 in development of their pressure ulcer scoring system, found that a patient's ability to turn was the single highest predictor of ulcer formation. Unfortunately in this study no decrease in pressure ulcer prevalence was observed. This may be secondary to an overall low pressure-ulcer occurrence rate, as both the pre-(2.6%) and postinitiative prevalence rate (4.6%) were far below the NHSN 25th percentile of 7.89%. Therefore, detecting a decrease in pressure ulcer formation may have been made more difficult given the already comparatively low prevalence on this unit.
These data suggest that increased mobility is feasible and safe for neurointensive care unit patients. A prospective cohort study of early ambulation by Bailey et al. 4 showed that in 103 ventilated patients, 1449 activity events were associated with less than 1% of activity-related adverse events during a 6-month study. However, there are considerable safety concerns that must be addressed prior to initiating such a program, which have been discussed elsewhere.
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There is a strong body of literature suggesting that venous thromboembolism should be affected by the increasing of mobility. Weill-Engerer et al. 34 showed that the rate of deep venous thrombosis was strongly correlated with restriction of mobility. Deep venous thrombosis formation was progressively more likely with decreasing mobility, from limited mobility without immobilization (OR = 1.73) to bedridden during the previous 15 days (OR = 5.64). Unfortunately, these data could not be reliably evaluated in our institution. Our neurointensive care unit does not routinely screen for venous thromboembolism and therefore any observed changes are not based on systematic observation.
Significant challenges were encountered during the implementation of this initiative. Namely, acquiring new equipment and support technician positions was not an easy task in such a fiscally difficult time. Acquiring hospital administration support for this initiative was imperative. Once identified as a patient care priority for improving quality outcomes, the financial resources were ultimately allocated. The Mobility Task Force was concerned that duplication of pilot unit efforts was paramount to achieving consistent success in every unit. For this reason, task force members believed strongly that all unit leadership should be given the Mobility Bundle Toolkit and Mobility Checklist for Managers. Lastly, changing unit and interdisciplinary culture proved to be the most difficult challenge in this endeavor. Extensive education about current evidence-based guidelines and mandatory enforcement of its completion by interdisciplinary leaders were pivotal in changing the status quo into a culture of early patient mobility and complication prevention.
Our study has several limitations. First, while mobility data were collected for the entire study period, intensive analysis and interpretation were only performed on two 2-week periods (pre-and postinitiative). In our opinion, further analysis would have been unduly cumbersome and would have added little to the overall weight of the results. Second, as with any nonrandomized study, the interpretation of results should be conducted with care and causality cannot be determined by the current results. While every attempt was made to control for extraneous factors, the role of unaccounted for variables cannot be determined in a correlational study such as this. These data suggest that further study is necessary and a randomized control trial should be instituted to investigate the influence of increased mobility in the ICU setting.
Conclusions
Current neurointensive care unit practice, with increasingly aggressive and continuous monitoring techniques, has demonstrated a shift toward sedation and inactivity. The lack of mobility in ICU patients has been well established in previous nonneurological work, as has its detrimental outcomes. Recent literature has begun to recognize the physiological benefits of increased mobility in ICU patients, focusing mostly on ventilated medical ICU wards. However, in this paper we present only the second study to investigate the implementation of a comprehensive mobility program (PUMP Plus) and the first reported such initiative in a neurointensive care unit population and the first in a predominantly surgical population. We believe that the significant effect on hospital-acquired infections and limitation of restraint merit further randomized control trials as a means to broader implementation.
When we first started our unit in 1964, patients who required mechanical ventilation were awake and alert and often sitting in a chair . . . these individuals could interact . . . they could feel human. . . .The requirement of high acuity care and available pharmacologic therapy has led to the present situation . . . the awake and alert patient who is anxious or depressed requires a great amount of interaction with the health care team. . . . Understanding of the delicate machine/patient interface seems to be lost these days; thus, the requirement of sedation and paralysis.
Thomas L. PeTTy, m.D.
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